272 related articles for article (PubMed ID: 20971820)
1. Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia.
Balgobind BV; Van den Heuvel-Eibrink MM; De Menezes RX; Reinhardt D; Hollink IH; Arentsen-Peters ST; van Wering ER; Kaspers GJ; Cloos J; de Bont ES; Cayuela JM; Baruchel A; Meyer C; Marschalek R; Trka J; Stary J; Beverloo HB; Pieters R; Zwaan CM; den Boer ML
Haematologica; 2011 Feb; 96(2):221-30. PubMed ID: 20971820
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia.
Balgobind BV; Hollink IH; Arentsen-Peters ST; Zimmermann M; Harbott J; Beverloo HB; von Bergh AR; Cloos J; Kaspers GJ; de Haas V; Zemanova Z; Stary J; Cayuela JM; Baruchel A; Creutzig U; Reinhardt D; Pieters R; Zwaan CM; van den Heuvel-Eibrink MM
Haematologica; 2011 Oct; 96(10):1478-87. PubMed ID: 21791472
[TBL] [Abstract][Full Text] [Related]
3. Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
Langer C; Marcucci G; Holland KB; Radmacher MD; Maharry K; Paschka P; Whitman SP; Mrózek K; Baldus CD; Vij R; Powell BL; Carroll AJ; Kolitz JE; Caligiuri MA; Larson RA; Bloomfield CD
J Clin Oncol; 2009 Jul; 27(19):3198-204. PubMed ID: 19451432
[TBL] [Abstract][Full Text] [Related]
4. Classification of pediatric acute myeloid leukemia based on miRNA expression profiles.
Obulkasim A; Katsman-Kuipers JE; Verboon L; Sanders M; Touw I; Jongen-Lavrencic M; Pieters R; Klusmann JH; Michel Zwaan C; van den Heuvel-Eibrink MM; Fornerod M
Oncotarget; 2017 May; 8(20):33078-33085. PubMed ID: 28380436
[TBL] [Abstract][Full Text] [Related]
5. Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome.
Dufour A; Schneider F; Metzeler KH; Hoster E; Schneider S; Zellmeier E; Benthaus T; Sauerland MC; Berdel WE; Büchner T; Wörmann B; Braess J; Hiddemann W; Bohlander SK; Spiekermann K
J Clin Oncol; 2010 Feb; 28(4):570-7. PubMed ID: 20038735
[TBL] [Abstract][Full Text] [Related]
6. Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias.
Mullighan CG; Kennedy A; Zhou X; Radtke I; Phillips LA; Shurtleff SA; Downing JR
Leukemia; 2007 Sep; 21(9):2000-9. PubMed ID: 17597811
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia.
Steudel C; Wermke M; Schaich M; Schäkel U; Illmer T; Ehninger G; Thiede C
Genes Chromosomes Cancer; 2003 Jul; 37(3):237-51. PubMed ID: 12759922
[TBL] [Abstract][Full Text] [Related]
8. Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling.
Verhaak RG; Wouters BJ; Erpelinck CA; Abbas S; Beverloo HB; Lugthart S; Löwenberg B; Delwel R; Valk PJ
Haematologica; 2009 Jan; 94(1):131-4. PubMed ID: 18838472
[TBL] [Abstract][Full Text] [Related]
9. AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features.
Haferlach T; Kohlmann A; Klein HU; Ruckert C; Dugas M; Williams PM; Kern W; Schnittger S; Bacher U; Löffler H; Haferlach C
Leukemia; 2009 May; 23(5):934-43. PubMed ID: 19194466
[TBL] [Abstract][Full Text] [Related]
10. Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia.
Danen-van Oorschot AA; Kuipers JE; Arentsen-Peters S; Schotte D; de Haas V; Trka J; Baruchel A; Reinhardt D; Pieters R; Zwaan CM; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2012 May; 58(5):715-21. PubMed ID: 21818844
[TBL] [Abstract][Full Text] [Related]
11. FLT3-ITD and MLL-PTD influence the expression of MDR-1, MRP-1, and BCRP mRNA but not LRP mRNA assessed with RQ-PCR method in adult acute myeloid leukemia.
Nasilowska-Adamska B; Solarska I; Paluszewska M; Malinowska I; Jedrzejczak WW; Warzocha K
Ann Hematol; 2014 Apr; 93(4):577-93. PubMed ID: 24030729
[TBL] [Abstract][Full Text] [Related]
12. DNA Methylation Signatures Predict Cytogenetic Subtype and Outcome in Pediatric Acute Myeloid Leukemia (AML).
Krali O; Palle J; Bäcklin CL; Abrahamsson J; Norén-Nyström U; Hasle H; Jahnukainen K; Jónsson ÓG; Hovland R; Lausen B; Larsson R; Palmqvist L; Staffas A; Zeller B; Nordlund J
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34200630
[TBL] [Abstract][Full Text] [Related]
13. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
Schlenk RF; Döhner K; Krauter J; Fröhling S; Corbacioglu A; Bullinger L; Habdank M; Späth D; Morgan M; Benner A; Schlegelberger B; Heil G; Ganser A; Döhner H;
N Engl J Med; 2008 May; 358(18):1909-18. PubMed ID: 18450602
[TBL] [Abstract][Full Text] [Related]
14. High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study.
Langer C; Radmacher MD; Ruppert AS; Whitman SP; Paschka P; Mrózek K; Baldus CD; Vukosavljevic T; Liu CG; Ross ME; Powell BL; de la Chapelle A; Kolitz JE; Larson RA; Marcucci G; Bloomfield CD;
Blood; 2008 Jun; 111(11):5371-9. PubMed ID: 18378853
[TBL] [Abstract][Full Text] [Related]
15. High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study.
Marcucci G; Maharry K; Whitman SP; Vukosavljevic T; Paschka P; Langer C; Mrózek K; Baldus CD; Carroll AJ; Powell BL; Kolitz JE; Larson RA; Bloomfield CD;
J Clin Oncol; 2007 Aug; 25(22):3337-43. PubMed ID: 17577018
[TBL] [Abstract][Full Text] [Related]
16. Expression of HOXB genes is significantly different in acute myeloid leukemia with a partial tandem duplication of MLL vs. a MLL translocation: a cross-laboratory study.
Liu HC; Shih LY; May Chen MJ; Wang CC; Yeh TC; Lin TH; Chen CY; Lin CJ; Liang DC
Cancer Genet; 2011 May; 204(5):252-9. PubMed ID: 21665178
[TBL] [Abstract][Full Text] [Related]
17. Quantitative acute leukemia cytogenetics.
Mitelman F; Heim S
Genes Chromosomes Cancer; 1992 Jul; 5(1):57-66. PubMed ID: 1384663
[TBL] [Abstract][Full Text] [Related]
18. HOX expression patterns identify a common signature for favorable AML.
Andreeff M; Ruvolo V; Gadgil S; Zeng C; Coombes K; Chen W; Kornblau S; Barón AE; Drabkin HA
Leukemia; 2008 Nov; 22(11):2041-7. PubMed ID: 18668134
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of gene mutations in acute myeloid leukemia with normal cytogenetics.
Gaidzik V; Döhner K
Semin Oncol; 2008 Aug; 35(4):346-55. PubMed ID: 18692685
[TBL] [Abstract][Full Text] [Related]
20. [Clinical characteristics and prognosis of 34 cases of acute myeloid leukemia with FLT3 internal tandem duplication and MLL gene rearrangement].
Zhou JR; Zhang X; Zhao YL; Yang JF; Zhang JP; Cao XY; Lu Y; Liu DY; Lyu FY; Ouyang J; Lu PH
Zhonghua Xue Ye Xue Za Zhi; 2018 Sep; 39(9):751-756. PubMed ID: 30369187
[No Abstract] [Full Text] [Related]
[Next] [New Search]
